In vitro effect of cyclosporin A on immunoglobulin production and concanavalin A induced suppression in primary biliary cirrhosis (Q34529385)

2 August 2017

title

In vitro effect of cyclosporin A on immunoglobulin production and concanavalin A induced suppression in primary biliary cirrhosis (English)

1 reference

primary biliary cholangitis

2 August 2017

main subject

0 references

1 reference

Al-Aghbar MN

1

1 reference

2 August 2017

Alexander GJ

2

1 reference

2 August 2017

Nouri-Aria KT

3

1 reference

2 August 2017

Neuberger J

4

1 reference

2 August 2017

Eddleston AL

5

1 reference

2 August 2017

Williams R

6

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 March 1986

1 reference

2 August 2017

1 reference

2 August 2017

volume

27

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

317-323

1 reference

Liver transplantation, 1980, with particular reference to cyclosporin-A.

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433424

Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onset

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433424

Selective suppression of an early step in human B cell activation by cyclosporin A

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433424

Effects of the new anti-lymphocytic peptide cyclosporin A in animals

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433424

Cyclosporin A: an immunosuppressive agent preferentially active against proliferating T cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433424

Lymphocyte subsets and integrated immune function in aging humans

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433424

Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433424

Effects of cyclosporin A on the metabolism of unstimulated and mitogen-activated lymphocytes.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433424

Selective effects of cyclosporin A on functional B cell subsets in the mouse

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433424

The late results of long-term treatment of primary biliary cirrhosis by corticosteroids

27 October 2018

1 reference

12 December 2020

Effect of steroid therapy on the clinical and laboratory features of primary biliary cirrhosis

1 reference

12 December 2020

Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR

1 reference

12 December 2020

Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process

1 reference

12 December 2020

Abnormal regulation of immunoglobulin synthesis in vitro in primary biliary cirrhosis

1 reference

12 December 2020

Effects of cyclosporin A on suppressor and inducer T lymphocytes in primary biliary cirrhosis

1 reference

12 December 2020

Cyclosporin A blocks receptors for HLA-DR antigens on T cells

1 reference

12 December 2020

Suppressive effects of cyclosporin A on the induction of alloreactivity in vitro and in vivo

1 reference

12 December 2020

Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2

1 reference

12 December 2020

Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on mitogen-stimulated human T cells

1 reference

12 December 2020

Genetic abnormalities of immunoregulation in primary biliary cirrhosis

1 reference

12 December 2020

Treatment of intraocular inflammatory disease with cyclosporin A

1 reference

12 December 2020

Experimental erythrocyte autoimmunity prevented by suppressor T cells in mice treated with Cyclosporin-A

1 reference

12 December 2020

Cyclosporin improves Graves' ophthalmopathy

1 reference

12 December 2020

Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig

1 reference

12 December 2020

Cyclosporin for Crohn's disease

1 reference

12 December 2020

Cyclosporin for pulmonary sarcoidosis

1 reference

12 December 2020

HLA A1-B8-DR3 and suppressor cell function in first-degree relatives of patients with autoimmune chronic active hepatitis

1 reference

12 December 2020

A classification of chronic hepatitis

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.27.3.317

1 reference

2 August 2017

1 reference

2 August 2017

1 reference